pCI-MS2V5-PABPC1 Citations (5)
Originally described in: The interaction of cytoplasmic poly(A)-binding protein with eukaryotic initiation factor 4G suppresses nonsense-mediated mRNA decay.Fatscher T, Boehm V, Weiche B, Gehring NH RNA. 2014 Oct;20(10):1579-92. doi: 10.1261/rna.044933.114. Epub 2014 Aug 21. PubMed Journal
Articles Citing pCI-MS2V5-PABPC1
Articles |
---|
RNase L promotes the formation of unique ribonucleoprotein granules distinct from stress granules. Burke JM, Lester ET, Tauber D, Parker R. J Biol Chem. 2020 Feb 7;295(6):1426-1438. doi: 10.1074/jbc.RA119.011638. Epub 2020 Jan 2. PubMed |
Stress granules inhibit fatty acid oxidation by modulating mitochondrial permeability. Amen T, Kaganovich D. Cell Rep. 2021 Jun 15;35(11):109237. doi: 10.1016/j.celrep.2021.109237. PubMed |
Development of a Tethered mRNA Amplifier to increase protein expression. Torkzaban B, Kawalerski R, Coller J. Biotechnol J. 2022 Jul 4:e2200214. doi: 10.1002/biot.202200214. PubMed |
RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus. Burke JM, Ripin N, Ferretti MB, St Clair LA, Worden-Sapper ER, Salgado F, Sawyer SL, Perera R, Lynch KW, Parker R. PLoS Pathog. 2022 Nov 1;18(11):e1010930. doi: 10.1371/journal.ppat.1010930. eCollection 2022 Nov. PubMed |
Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis. Li K, Sun X, Minami K, Tamari K, Ogawa K, Li H, Ma H, Zhou M, Na S, Li BY, Yokota H. Theranostics. 2023 Feb 5;13(4):1247-1263. doi: 10.7150/thno.80294. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.